Atpase inhibitory factor‐1 disrupts mitochondrial ca2+ handling and promotes pathological cardiac hypertrophy through camkiiδ

Abstract

ATPase inhibitory factor‐1 (IF1) preserves cellular ATP under conditions of respiratory collapse, yet the function of IF1 under normal respiring conditions is unresolved. We tested the hypothesis that IF1 promotes mitochondrial dysfunction and pathological cardiomyocyte hyper-trophy in the context of heart failure (HF). Methods and results: Cardiac expression of IF1 was in-creased in mice and in humans with HF, downstream of neurohumoral signaling pathways and in patterns that resembled the fetal‐like gene program. Adenoviral expression of wild‐type IF1 in pri-mary cardiomyocytes resulted in pathological hypertrophy and metabolic remodeling as evi-denced by enhanced mitochondrial oxidative stress, reduced mitochondrial respiratory capacity, and the augmentation of extramitochondrial glycolysis. Similar perturbations were observed with an IF1 mutant incapable of binding to ATP synthase (E55A mutation), an indication that these effects occurred independent of binding to ATP synthase. Instead, IF1 promoted mitochondrial fragmentation and compromised mitochondrial Ca2+ handling, which resulted in sarcoplasmic re‐ticu-lum Ca2+ overloading. The effects of IF1 on Ca2+ handling were associated with the cytosolic activation of calcium–calmodulin kinase II (CaMKII) and inhibition of CaMKII or co‐expression of cat-alytically dead CaMKIIδC was sufficient to prevent IF1 induced pathological hypertrophy. Conclu-sions: IF1 represents a novel member of the fetal‐like gene program that contributes to mi‐tochon-drial dysfunction and pathological cardiac remodeling in HF. Furthermore, we present ev‐idence for a novel, ATP‐synthase‐independent, role for IF1 in mitochondrial Ca2+ handling and mitochon-drial‐to‐nuclear crosstalk involving CaMKII.